Table 2.
Outcome | Female | Male | Sig. | Czech | Non-Czech | Sig. | HCS | Non-HCS | Sig. | Total |
---|---|---|---|---|---|---|---|---|---|---|
COVID-19 Infection | 257 (28.5%) | 141 (32.1%) | 0.169 | 347 (30.4%) | 53 (25.4%) | 0.143 | 169 (30.8%) | 231 (28.8%) | 0.434 | 400 (29.6%) |
Providing Care | 303 (33.6%) | 135 (30.8%) | 0.304 | 387 (33.9%) | 55 (26.3%) | 0.032 | 211 (38.4%) | 231 (28.8%) | <0.001 | 442 (32.7%) |
Knowing Patient | 893 (98.9%) | 434 (98.9%) | 0.959 | 1128 (98.8%) | 207 (99%) | 0.741 | 542 (98.7%) | 793 (98.9%) | 0.799 | 1335 (98.8%) |
Knowing Dead | 329 (36.4%) | 141 (32.1%) | 0.120 | 404 (35.4%) | 68 (32.5%) | 0.428 | 188 (34.2%) | 284 (35.4%) | 0.658 | 472 (34.9%) |
Flu Vaccine | 177 (19.6%) | 100 (22.8%) | 0.177 | 214 (18.7%) | 66 (31.6%) | <0.001 | 133 (24.2%) | 147 (18.3%) | 0.009 | 280 (20.7%) |
Recent Flu Vaccine | 78 (44.6%) | 46 (46%) | 0.819 | 98 (46%) | 27 (41.5%) | 0.526 | 84 (63.6%) | 41 (28.1%) | <0.001 | 125 (45%) |
HCS = Healthcare Students. Non-HCS = Non-Healthcare Students. Chi-squared test (χ2) was used with a significance level (Sig.) of ≤0.05.